Please assess the completion status of the following clinical trial:

Trial Title: European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
There will be no specific medical inclusion/exclusion criteria and no age restrictions~Inclusion Criteria:~* First ever user of a combined hormonal contraceptive starter~* User who restarts a combined hormonal contraceptive after at leat a two month break restarter~* Women willing to participate in an active surveillance study~Exclusion Criteria:~- Women who do not understand the major aspects of the study

- Gender: FEMALE
- Minimum Age: 14 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- FC patch low (Type: None): Women taking FC Patch low, a transdermal patch releasing 60 micrograms gestodene/24 hours + 13 micrograms ethinyl estradiol/24 hours
- LNG-COC (Type: None): Women taking levonorgestrel-containing COCs: 1) monophasic preparations containing 20 - 30mcg of ethinylestradiol; 2) multiphasic preparations containing up to 40mcg of ethinylestradiol

Based on this trial design, predict the completion outcome and termination type (if applicable).